GlassScriptPhysician profile
Sorin Brener
NPI 1104930338
$166,239.01
in general payments reported to CMS, 2019-2025
16 companies · $13K in 2025
The $13K reported for 2025 was more than what 90% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48K · 2020: $25K · 2021: $23K · 2022: $20K · 2023: $25K · 2024: $12K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $37K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,600 · Food and Beverage: $2,904 · Travel and Lodging: $2,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $36,941.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,600.00 |
| Food and Beverage | $2,903.69 |
| Travel and Lodging | $2,004.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $114,043.88 | 2019-2023 | Brilinta |
| Abbott Laboratories | $42,543.63 | 2019-2025 | Xience V, Xience Skypoint, Xience Xpedition |
| Medtronic Vascular, INC. | $5,331.20 | 2019 | |
| Contego Medical, INC | $2,000.00 | 2021 | |
| Boston Scientific Corporation | $541.97 | 2021-2023 | Avvigo Guidance System, Stingray |
| Abiomed | $439.71 | 2019-2024 | Impella |
| Edwards Lifesciences Corporation | $403.61 | 2019-2024 | Sapien 3 Ultra Resilia |
| Medtronic, INC. | $354.64 | 2021-2024 | Corevalve Evolut R, Linq II |
| Siemens Medical Solutions USA, INC. | $167.76 | 2022 | |
| Biotronik INC. | $123.82 | 2022 | |
| Terumo Medical Corporation | $122.82 | 2023 | Angio-Seal |
| Novartis Pharmaceuticals Corporation | $53.92 | 2019-2024 | |
| Irhythm Technologies, INC. | $43.97 | 2024 | Zio Monitor, Zio Xt Patch |
| Amgen INC. | $24.34 | 2021 | |
| Chiesi USA, INC. | $22.22 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $21.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$20,275.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sorin Brener listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.